TAM Global Founder and Chief Scientific Advisor Publishes First-Principles Framework for Accelerating Translational Medicine
A newly published commentary by TAM Global founder Edward Clay and Annette Marleau, Ph.D., proposes a first-principles framework for accelerating translational medicine and reducing the time it takes…
Read the full articleYou might also wanna read
Molecular tumor boards show promise in bridging precision oncology's translation gap
Molecular tumor boards translate complex genomic data to more effectively inform personalized care, and a new meta-analysis shows they boost
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
The country’s new regulatory pathway promises to accelerate access to advanced therapies for Chinese patients, but may change the licensing
China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness
Theo Jaffee and Gabriel Dickinson speak with Cremieux about China’s rapid rise to the top of global clinical trial output. They discuss the

Enabling Widespread Adoption of Transformative Biopharmaceutical Technologies: Insights from Roundtable 1 of the 2025 BioInnovation Group Executive Summit
Summarizing insights from the first of six roundtable discussions at the September 2025 BioInnovation Group (BIG) Executive Summit, this art
China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness
Theo Jaffee and Gabriel Dickinson speak with Cremieux about China’s rapid rise to the top of global clinical trial output. They discuss the
Traitements contre le cancer : «La Chine est en train de devenir le leader mondial du médicament»
Les investissements de la Chine dans l’innovation et l’industrie pharmaceutique sont colossaux

Comments
Sign in to join the conversation.
No comments yet. Be the first.